lenvima capsule
eisai limited - lenvatinib (lenvatinib mesylate) - capsule - 14mg - lenvatinib (lenvatinib mesylate) 14mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (lenvatinib mesylate) - capsule - 10mg - lenvatinib (lenvatinib mesylate) 10mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (lenvatinib mesylate) - capsule - 8mg - lenvatinib (lenvatinib mesylate) 8mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (lenvatinib mesylate) - capsule - 18mg - lenvatinib (lenvatinib mesylate) 18mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (lenvatinib mesylate) - capsule - 4mg - lenvatinib (lenvatinib mesylate) 4mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (lenvatinib mesylate) - capsule - 12mg - lenvatinib (lenvatinib mesylate) 12mg - antineoplastic agents
lutathera solution
novartis pharmaceuticals canada inc - lutetium (177lu) oxodotreotide - solution - 370mbq - lutetium (177lu) oxodotreotide 370mbq - antineoplastic agents
lenvima 4 mg hard capsules
eisai (malaysia) sdn bhd (18039-d) - lenvatinib mesilate -
lenvima 10mg hard capsules
eisai (malaysia) sdn bhd (18039-d) - lenvatinib mesilate -